Skip to main content
. 2021 Oct 15;9(10):1479. doi: 10.3390/biomedicines9101479

Table 1.

Demographic data of the enrolled participants.

Healthy Controls
(n = 29)
LTBI-ALL
(n = 58)
LTBI-ALL
LTBI-Non-CKD
(n = 19)
LTBI-ESRD
(n = 39)
Age, year 57.7 ± 15.0 * 57.4 ± 13.3 49.1 ± 15.7 61.5 ± 9.8
Male sex 17 (58.6) * 37(63.8) 9 (47.4) 28 (71.8)
Smoking 3 (10.3) 13(22.4) 1 (5.3) 12 (30.8)
BMI 23.6 ± 3.8 23.7 ± 3.6 23.7 ± 4.1 23.7 ± 3.4
Underlying disease
ESRD 0 39(67.2) 0 39(100)
Malignancy 0 1(1.7) 1 (5.3) 0
Cirrhosis of liver 0 0 0 0
Diabetes mellitus 6 (20.7) 8(13.8) 1 (5.3) 7 (17.9)
Radiographic findings
No lesion 26 (89.7) 55(94.8) 18 (94.7) 37 (92.5)
Lesion, not related to TB 3 (10.3) 3(5.2) 1 (5.3) 3 (7.7)
Lesion, prior TB 0 0 0 0
Hemoglobin, g/dL 13.8 ± 1.5 * 11.8 ± 1.7 12.5 ± 2.0 11.4 ± 1.5
Blood leukocyte count,/μL 6920 ± 1398 7050 ± 2332 7560 ± 2607 6801 ± 2178

Abbreviations: BMI, body mass index; CKD, chronic kidney disease; ESRD, end stage renal disease; LTBI, latent tuberculosis infection; TB, tuberculosis Data are presented as number (%) or mean ± standard deviation. * Statistical significance between healthy controls and LTBI-non-CKD group. # Statistical significance between healthy controls and LTBI-ESRD group. Statistical significance between LTBI-non-CKD and LTBI-ESRD group. § Statistical significance between healthy controls and LTBI-ALL group.